Drug/chemical-induced diabetes mellitus can lead to severe non-proliferative retinopathy with macular edema, which is a significant complication affecting vision. This condition arises from the toxic effects of certain medications or chemicals on pancreatic function, resulting in hyperglycemia and subsequent ocular complications. Accurate coding with ICD-10 Code E09.3419 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this serious condition.
ICD-10 Code E09.3419 represents drug or chemical-induced diabetes mellitus with severe non-proliferative retinopathy and macular edema, unspecified. This code should be used when documenting cases where diabetes is a direct result of pharmacological agents, leading to significant ocular complications. It is crucial for accurate clinical documentation and billing, particularly in cases where the underlying cause is linked to medication use.
Drug/chemical-induced diabetes mellitus can progress to severe non-proliferative retinopathy with macular edema, necessitating immediate medical attention. This condition is often caused by certain medications that impair insulin secretion or action, leading to chronic hyperglycemia and subsequent retinal damage. Early recognition and intervention are critical to prevent irreversible vision loss.
ICD-10 Code E09.3419 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to drug-induced diabetes and its ocular complications. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition and facilitating appropriate management.
In SOAP notes, ICD-10 Code E09.3419 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of drug-induced diabetes with severe ocular complications. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of drug-induced diabetes with severe non-proliferative retinopathy and macular edema requires a multifaceted approach, emphasizing the urgency of treatment to prevent further complications.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code E09.3419 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, moderate complexity. |
| 92014 | Ophthalmological examination, established patient. |
| 83036 | Hemoglobin A1c test for diabetes management. |
Common Questions About Using ICD-10 Code E09.3419 for Drug/chem diab with severe nonp rtnop with mclr edema, unsp
What medications can cause drug-induced diabetes?
Certain medications, including corticosteroids, antipsychotics, and some antihypertensives, can induce diabetes by affecting insulin secretion or action.
How is severe non-proliferative retinopathy diagnosed?
Severe non-proliferative retinopathy is diagnosed through a comprehensive eye exam, including fundoscopic evaluation and imaging techniques like optical coherence tomography.
What are the treatment options for macular edema?
Treatment for macular edema may include intravitreal injections of anti-VEGF agents, corticosteroids, or laser therapy, depending on the severity and underlying cause.
Is hospitalization required for this condition?
Hospitalization may be necessary for severe cases requiring intensive management of blood glucose levels or urgent ophthalmologic intervention.
Clinical Notes
SOAP notes
DAP notes
AI medical notes